Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The European Union Allocates Six Million Euros to Study Prevention Strategies Tumors Caused by HPV

Published: Tuesday, November 05, 2013
Last Updated: Tuesday, November 05, 2013
Bookmark and Share
The human papillomavirus (HPV) is responsible for cervical cancer and is behind a significant percentage of other tumors such as vulva , vagina, penis, anus, and oropharynx.

It is estimated that, in Europe , every year 30,000 women die as a result of cervical cancer, especially in the Eastern countries , where screening programs are not consolidated.

The consortium CoheaHr wants to provide scientific evidence for the clinical effectiveness and cost - effectiveness of different strategies to prevent cervical cancer throughout the European Union. To assess strategies focus on screening for HPV detection and vaccination. Specifically, the consortium conducted four clinical trials:

•    Compare the results of sampling for HPV testing when performed by the patient herself and when you get a health care professional, and their possible implementation as a method to increase screening coverage.
•    To determine the subsequent most appropriate time intervals and the use of HPV screening test for subsequent monitoring of :
      o    Women in age to start screening, vaccinated  during adolescence
      o    Young women vaccinated two years before the start of screening.
•    To assess the feasibility and acceptance of the HPV vaccine by the women entering the routine screening between 25-45 years.

The results of the different components will be incorporated into transmission models, economic and impact made by the consortium to make projections of different preventive interventions.

The consortium is committed to producing systematic reviews that allow summarizing the evidence generated in the medical literature and contribute to the dissemination of research results.

CoheaHr consortium with the participation of twelve partners from eleven countries: Amsterdam, Barcelona, Tampere, London, Turin, Stockholm, Brussels, Ljubljana, Lyon, Copenhagen, Reims and Wolfsburg. The Research Program in Cancer Epidemiology ICO lead two areas of work, the study of acceptance of the vaccine in women aged 25-45 years and scientific dissemination activities.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Monkeys Protected by Zika DNA Vaccine
Experimental Zika virus DNA vaccines successfully protected monkeys against Zika infection.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!